Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment
- PMID: 24561014
- DOI: 10.1016/j.trim.2014.02.002
Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment
Abstract
Objective: Regulatory Foxp3-expressing T cells (Tregs), IL-10-producing B cells (Bregs), and IDO-expressing dendritic cells (DCregs) downregulate inflammatory processes and induce peripheral tolerance, while Th17A and Th22 cell subpopulations are of proinflammatory nature. The aims of the study were to characterize and to enumerate peripheral Tregs, Bregs, and DCregs and Th17A and Th22 cell subpopulations in kidney transplant recipients (KTRs) under belatacept or cyclosporine treatment.
Methods: Forty-one KRT patients (30 under belatacept treatment and 11 under cyclosporine treatment) and 26 healthy donors (HDs) were included in the study. CD19(+)-expressing peripheral B lymphocytes were purified by positive selection. IL-10-producing B cells, CD4(+)/CD25(high)Foxp3(+), and CD8(+)/CD28(-)Foxp3(+) Tregs, CCR6(+)/CD123(+)/IDO(+) DCs, as well as Th17A and Th22 cell subpopulations were quantitated by flow cytometry.
Results: Of the IL-10-producing Bregs, CD19(+)/CD24(high)/CD38(high)/CD5(+), CD19(+)/CD24(high)/CD38(high)/CD10(+), CD19(+)/CD24(high)/CD38(high)/CD20(+), and CD19(+)/CD24(high)/CD38(high)/CD27(-) had significant higher frequency in patients under belatacept treatment when compared with those under cyclosporine. Only CD19(+)/CD24(high)/CD38(high)/CD27(+) and CD19(+)/CD24(high)/CD38(high)/CXCR7(+) cells had significant higher frequency in patients under cycloporine treatment when compared to those under belatacept. The percentages of IDO-expressing pDC, CD4(+)/CD25(high)Foxp3(+), and CD8(+)/CD28(-)Foxp3(+) were significantly higher in the belatacept group when compared the cyclosporine one, while Th17A and Th22 cells had significant higher frequency in the latter group.
Conclusion: Belatacept seems to maintain and enhance, at least systemically, a tolerant profile to renal allograft in transplant recipients by means of higher circulatory frequencies of regulatory B, T and pDC subpopulations.
Keywords: Belatacept; Cyclospirine; Kidney transplantation; Proinflammatory cells; Regulatory cells.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment.Transplant Proc. 2010 Nov;42(9):3489-96. doi: 10.1016/j.transproceed.2010.08.037. Transplant Proc. 2010. PMID: 21094802 Clinical Trial.
-
Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.Arthritis Res Ther. 2013;15(3):R68. doi: 10.1186/ar4245. Arthritis Res Ther. 2013. PMID: 23800367 Free PMC article.
-
Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.Transpl Immunol. 2007 Jun;17(4):243-8. doi: 10.1016/j.trim.2007.01.005. Epub 2007 Jan 24. Transpl Immunol. 2007. PMID: 17493526 Clinical Trial.
-
Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.Pharmacotherapy. 2011 Apr;31(4):394-407. doi: 10.1592/phco.31.4.394. Pharmacotherapy. 2011. PMID: 21449628 Review.
-
Belatacept in kidney transplantation.Curr Opin Organ Transplant. 2012 Dec;17(6):640-7. doi: 10.1097/MOT.0b013e32835a4c0d. Curr Opin Organ Transplant. 2012. PMID: 23044530 Review.
Cited by
-
Leprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Disease.Front Immunol. 2017 Nov 28;8:1635. doi: 10.3389/fimmu.2017.01635. eCollection 2017. Front Immunol. 2017. PMID: 29234318 Free PMC article. Review.
-
Regulatory B cells: TIM-1, transplant tolerance, and rejection.Immunol Rev. 2021 Jan;299(1):31-44. doi: 10.1111/imr.12933. Epub 2021 Jan 22. Immunol Rev. 2021. PMID: 33484008 Free PMC article. Review.
-
Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients.Front Immunol. 2017 Mar 3;8:219. doi: 10.3389/fimmu.2017.00219. eCollection 2017. Front Immunol. 2017. PMID: 28316600 Free PMC article.
-
Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects.Drugs. 2015 Nov;75(16):1843-52. doi: 10.1007/s40265-015-0487-6. Drugs. 2015. PMID: 26493288 Review.
-
Kynurenine Pathway after Kidney Transplantation: Friend or Foe?Int J Mol Sci. 2024 Sep 14;25(18):9940. doi: 10.3390/ijms25189940. Int J Mol Sci. 2024. PMID: 39337426 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials